Omeros Corp (OMER.OQ)
24 Jun 2016
* Entered into an amendment to its existing credit facility to provide company with an additional $20 million in unrestricted cash
* Omeros corporation reports first quarter 2016 financial results
* Omeros Corporation announces exclusive middle east distribution agreement for omidria
* Files for stock shelf of up to $100 million - sec filing Source text : http://1.usa.gov/1PaGHd2 Further company coverage:
* Files for mixed shelf of up to $100 million - sec filing Source text :http://1.usa.gov/1QVyHRy Further company coverage
|Johnson & Johnson (JNJ.N)||$115.63||-1.75|
|Novartis AG (NOVN.S)||CHF75.75||-1.20|
|Pfizer Inc. (PFE.N)||$33.97||-0.62|
|Roche Holding Ltd. (ROG.S)||CHF241.00||-5.50|
|Roche Holding Ltd. (RO.S)||CHF246.20||-3.30|
|Merck & Co., Inc. (MRK.N)||$55.88||-1.80|
|Bayer AG (BAYGn.DE)||€87.64||-5.53|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€69.37||-2.63|
|Eli Lilly and Co (LLY.N)||$74.33||+0.39|
Earnings vs. Estimates
Analyst Research Reports
Omeros Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of OMEROS CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider : Jefferson Research
Provider : Ford Investor Services, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.